Neuro Advance Boston is an off-the-record forum that brings together CMOs, CSOs, CEOs, and Heads of Neuro from top biopharmaceutical companies in the neuroscience and pain management space.

Dr Yann Godfrin, Chief Executive Officer, will attend the conference on October 11th 2017 at Harvard Medical School .